A shadow market for unapproved weight-loss drugs is being driven by TikTok fitness influencers and sellers on communication apps, according to new investigations.
Investigational Drug Gaining Popularity Via Social Media
Retatrutide, which is still in research studies, is being advertised by online personalities for its supposed weight-reducing properties. Viewers are encouraged to contact these accounts directly for supplier links, while also receiving promotional offers.
Thriving Commerce on Social Networks
Additionally, a robust market exists on Telegram, where communities with thousands of participants share “before and after” images, injection guides and assertions of next-day UK delivery. Vendors promote the drug there before directing buyers to WhatsApp for purchases.
Understanding Retatrutide
This medication is an investigational injection created by US drugmaker Eli Lilly. The treatment targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials suggest it could help patients lose up to 25% of their total weight. Referred to as the “triple G”, the drug is being promoted digitally as the next Ozempic.
Healthcare Professionals Voice Concerns
Nevertheless, doctors and chemists have cautions that the sale of what remains an unlicensed medication in the United Kingdom is a cause for concern and could result in users injecting products of uncertain source.
Several experts stated the demand for retatrutide could be connected to the increasing cost of approved weight loss treatments such as Mounjaro.
Regulatory Position and Implementation
Marketing retatrutide on social media or Telegram is prohibited in the United Kingdom, as it is an unlicensed medication that must not be marketed or distributed for human use under the Human Medicines Regulations 2012.
Some influencers try to circumvent the rules by calling to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but advertising and supply can still violate pharmaceutical, advertising, and customer laws, potentially leading to fines, prosecution or prison.
Platform Reaction and Material Elimination
Based on TikTok, the service has removed violative material and prohibited related keywords and query recommendations. The organization said it was committed to keeping the platform safe and investing in strengthening compliance measures.
Online Marketplace Activities
Investigations also discovered communities with up to 9,000 members selling the experimental drug using the platform's integrated discovery tool, which operates like a online catalog. Typing “retatrutide” immediately displays channels with thousands of members, filled with photos of weight loss, glowing testimonials and step-by-step guides for preparing or injecting at home.
Within moments of entering one community, a seller shared contact information, where the majority of transactions take place. The vendor sent an guidebook and promised shipping within 48 hours. When questioned whether the substance was authentic, one seller said: “You can’t be sure.” Another shared a image of a alleged testing documentation. None inquired about weight, health issues or previous experience.
Product Information and Pricing
Inside these communities, posts show dark colored packages with postal service labels, stating to include new batches. One message read: “It took eight of us to load them this morning.”
Customers can select between powder vials, prepared at home with purified liquid, or pre-filled pens typically sold at £160 for 20 milligrams. When questioned how long a pen should be used, vendors give contradictory responses varying between a several days to “depends on your body”.
Platform Moderation and Safety Actions
A representative for the messaging service stated it regularly monitored harmful material on its service including content that promoted the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.
Medical Expert Cautions
“People are injecting materials they cannot confirm. Although the science behind retatrutide is sound, these digital products may not include what they advertise,” said a pharmacy expert, the director of pharmacy at Chemist4U.
A medical professional of Asda Online Doctor linked the increase in demand to current price rises for authorized weight-loss medications such as Mounjaro. “With costs rising, patients are turning to online platforms. But fake treatments are highly dangerous. You cannot know what’s contained or whether the environment they were produced in was clean,” she explained.
Her staff has previously seen patients injured by self-injection from unconfirmed suppliers. “We recognize the disappointment, but buying from Telegram or WhatsApp is taking chances with your health,” said the doctor. “These materials could be impure or improperly measured.”
Manufacturer Statement
A spokesperson from the pharmaceutical company stated retatrutide was in phase 3 clinical trials and had not been reviewed or approved by any government authority globally. “Consequently at this time no one can market [it] for personal consumption,” they said, adding that any product “falsely representing itself as a company investigational product not yet approved … may subject patients to possibly serious health risks”.
